Mark R Litzow Selected Research

Artificial Respiration (Mechanical Ventilation)

1/2021	Epidemiology, Risk Factors, and Outcomes of Diffuse Alveolar Hemorrhage After Hematopoietic Stem Cell Transplantation.
6/2003	Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark R Litzow Research Topics

Disease

81	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 08/2002
48	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2024 - 08/2004
45	Neoplasms (Cancer) 05/2024 - 07/2006
43	Leukemia 11/2023 - 02/2005
19	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023 - 12/2003
17	Hematologic Neoplasms (Hematological Malignancy) 05/2024 - 02/2005
17	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2023 - 11/2006
15	Primary Myelofibrosis (Myelosclerosis) 03/2024 - 08/2006
15	Philadelphia Chromosome 10/2022 - 05/2006
13	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2023 - 01/2002
12	Multiple Myeloma 12/2022 - 03/2006
8	Immunoglobulin Light-chain Amyloidosis 12/2010 - 11/2002
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 09/2005
6	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 11/2021 - 11/2006
6	Thrombocytopenia (Thrombopenia) 01/2021 - 09/2005
5	Lymphoma (Lymphomas) 09/2023 - 01/2016
5	Pathologic Complete Response 12/2021 - 08/2006
5	Acute Promyelocytic Leukemia 03/2017 - 07/2008
4	Infections 11/2017 - 05/2012
3	Residual Neoplasm 01/2022 - 04/2015
3	Bronchiolitis Obliterans Syndrome 01/2022 - 11/2013
3	Anemia 01/2021 - 08/2006
3	Cytokine Release Syndrome 01/2020 - 11/2018
3	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2020 - 11/2018
3	Venous Thromboembolism 02/2019 - 12/2015
3	Pain (Aches) 01/2019 - 06/2010
3	Mucositis 02/2017 - 09/2005
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2016 - 09/2008
2	Blast Crisis (Blast Phase) 01/2023 - 01/2021
2	Hematologic Diseases (Blood Diseases) 01/2023 - 11/2021
2	Obesity 01/2023 - 10/2010
2	Cytopenia 01/2022 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2015
2	Systemic Mastocytosis 01/2022 - 01/2022
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 09/2012
2	Hemorrhage 01/2021 - 03/2017

Drug/Important Bio-Agent (IBA)

13	venetoclaxIBA 03/2024 - 01/2020
12	blinatumomabIBA 12/2022 - 12/2011
11	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2024 - 08/2002
9	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 11/2006
9	Monoclonal AntibodiesIBA 01/2020 - 03/2007
8	Phosphotransferases (Kinase)IBA 11/2023 - 01/2002
7	Proteins (Proteins, Gene)FDA Link 11/2023 - 04/2006
7	Imatinib Mesylate (Gleevec)FDA Link 12/2016 - 01/2002
6	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2013
6	Tyrosine Kinase InhibitorsIBA 12/2018 - 10/2009
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2015 - 03/2006
5	Tyrosine (L-Tyrosine)FDA Link 11/2023 - 03/2007
5	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2023 - 05/2011
5	AnthracyclinesIBA 01/2023 - 09/2009
5	Biomarkers (Surrogate Marker)IBA 10/2021 - 05/2012
5	AntigensIBA 01/2019 - 03/2007
5	Rituximab (Mabthera)FDA Link 03/2016 - 12/2011
4	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 03/2024 - 04/2015
4	ruxolitinibIBA 01/2023 - 10/2011
4	Lenalidomide (CC 5013)FDA Link 01/2021 - 08/2006
4	Core Binding Factors (Core-Binding Factor)IBA 01/2021 - 01/2018
4	Immunoconjugates (Immunoconjugate)IBA 10/2020 - 06/2014
3	Cladribine FDA LinkGeneric 03/2024 - 08/2013
3	ChromatinIBA 12/2023 - 01/2022
3	nilotinib FDA Link 11/2023 - 10/2017
3	Decitabine FDA Link 01/2023 - 07/2009
3	SteroidsIBA 01/2023 - 01/2016
3	Asparaginase (Elspar)FDA Link 01/2023 - 08/2004
3	Azacitidine (5 Azacytidine)FDA Link 01/2023 - 08/2017
3	Melphalan (Alkeran)FDA LinkGeneric 12/2022 - 10/2008
3	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 04/2016
3	midostaurinIBA 01/2022 - 12/2020
3	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2021 - 09/2015
3	alvocidib (flavopiridol)IBA 10/2021 - 09/2015
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2021 - 02/2017
3	Inotuzumab OzogamicinIBA 01/2021 - 06/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 11/2018
3	CalicheamicinsIBA 01/2020 - 11/2014
2	Histone Deacetylase InhibitorsIBA 11/2023 - 11/2017
2	ponatinibIBA 11/2023 - 01/2018
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2023 - 06/2013
2	CreatinineIBA 12/2022 - 03/2016
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2020
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2022 - 01/2019
2	Calcineurin InhibitorsIBA 01/2022 - 01/2019
2	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2021 - 02/2016
2	Erythropoietin FDA Link 01/2021 - 02/2016
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 08/2006

Therapy/Procedure

86	Therapeutics 01/2024 - 08/2002
37	Drug Therapy (Chemotherapy) 05/2024 - 11/2002
33	Cell Transplantation 01/2023 - 02/2007
25	Hematopoietic Stem Cell Transplantation 01/2023 - 02/2005
21	Transplantation 01/2023 - 06/2002
20	Stem Cell Transplantation 01/2023 - 11/2002
13	Homologous Transplantation 01/2024 - 04/2006
8	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 08/2008 - 06/2002
7	Induction Chemotherapy 10/2022 - 01/2005
7	Immunotherapy 10/2020 - 01/2014
5	Autologous Transplantation 12/2022 - 02/2006
3	Consolidation Chemotherapy 01/2020 - 02/2006
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2005 - 12/2003
2	Palliative Care (Palliative Therapy) 05/2024 - 11/2021
2	Salvage Therapy 11/2023 - 01/2023
2	Artificial Respiration (Mechanical Ventilation) 01/2021 - 06/2003